Teliso-V (telisotuzumab vedotin) is pitching to become the first targeted cancer treatment for people with non-small cell lung cancer (NSCLC) whose tumours overexpress c-Met. The c-Met protein ...
Fidelity Advisor Semiconductors Fund earns an Above Average Process Pillar rating. The most meaningful contributor to the rating is the fund's excellent long-term risk-adjusted performance.
Today will be a largely cloudy day, and it will be mainly dry to start. In the afternoon, there will be an increased chance of a shower in spots. Less mild than yesterday. Tonight This evening ...
After hours: March 21 at 7:53:41 PM EDT Loading Chart for MET ...
After hours: March 20 at 4:05:10 PM EDT Loading Chart for MET-PE ...
Research and development of medical imaging and diagnostic technology previously licensed and subsequently acquired from Uniquest Pty Limited.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback